IR情報

2021/12/23~2022/05/25

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2022
05/254,4754,4824,4264,427-0.9%978,0002兆4695億+1.63%
05/244,4984,5094,4624,467-0.8%819,3002兆4918億+2.71%
05/234,4904,5224,4534,503+1.4%1,019,7002兆5119億+3.8%
05/204,4744,4944,4354,441-0.98%1,392,1002兆4773億+2.68%
05/194,4234,5034,3954,485-1.43%1,135,4002兆5018億+3.89%
05/184,4864,5554,4784,550+2.32%1,412,7002兆5381億+5.64%
05/174,4614,4744,4154,447+0.57%1,416,4002兆4806億+3.56%
05/164,3504,5044,3504,422+2.46%1,095,4002兆4667億+3.22%
05/1313:30 大塚製薬とアケビア社の腎性貧血治療薬におけるグローバルライセンス契約の終了について
05/1313:30 2022年12月期第1四半期決算短信〔IFRS〕(連結)
05/134,4004,4204,2504,316-1.82%1,840,3002兆4076億+0.91%
05/124,3964,4174,3394,396-0.57%855,8002兆4522億+2.83%
05/114,4064,4504,4014,421-0.45%895,0002兆4661億+3.58%
05/104,4244,4514,4054,441+0.05%870,8002兆4773億+4.22%
05/094,4954,5064,4194,439-1.86%936,9002兆4762億+4.35%
05/064,4444,5324,4114,523+2.26%1,517,2002兆5230億+6.5%
05/024,3514,4304,3034,423+1.38%1,225,6002兆4673億+4.41%
04/2816:00 譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ
04/284,2334,3764,1914,363+4%1,398,1002兆4338億+3.17%
04/274,2394,2394,1654,195-1.99%1,497,7002兆3401億-0.71%
04/264,2454,3034,2374,280+0.87%1,065,8002兆3875億+1.23%
04/254,2174,2544,1954,243+0.24%742,9002兆3668億+0.5%
04/224,2284,2434,1984,233-0.4%713,1002兆3613億+0.33%
04/214,2154,2824,1734,250+1.8%895,5002兆3708億+0.83%
04/204,1224,1774,1104,175+1.14%670,9002兆3289億-0.74%
04/194,1344,1514,1084,128+0.29%553,7002兆3027億-1.67%
04/184,1714,1844,0814,116-2.37%514,9002兆2960億-1.77%
04/154,2034,2364,1744,216-0.57%475,4002兆3518億+0.81%
04/144,1934,2584,1904,240+0.98%481,8002兆3652億+1.61%
04/134,1264,2134,1254,199+0.53%856,9002兆3423億+0.96%
04/124,2214,2354,1684,177-1.44%707,3002兆3300億+0.8%
04/114,2304,2474,2024,238+0.02%810,6002兆3641億+2.54%
04/084,2824,2824,2284,237-0.09%1,332,0002兆3635億+2.81%
04/074,1804,2484,1594,241+1.41%934,8002兆3657億+3.21%
04/064,2074,2254,1604,182-1.48%1,150,1002兆3328億+2.15%
04/054,3004,3034,2104,245-0.84%1,024,1002兆3680億+3.92%
04/044,2604,3024,2324,281+1.4%649,0002兆3880億+5.11%
04/014,2114,2254,1494,222-0.24%858,5002兆3551億+4.02%
03/314,2424,3074,2324,232-0.89%1,549,2002兆3607億+4.57%
03/318:30 腎性貧血治療薬「バダデュスタット」米国FDAから審査完了報告通知(CRL)を受理
03/3016:30 譲渡制限付株式報酬としての自己株式の処分に関するお知らせ
03/304,3004,3194,2294,270-0.02%871,6002兆3819億+5.77%
03/294,2414,2724,2194,271+0.9%865,8002兆3825億+6.06%
03/284,2584,2594,2114,233-0.8%558,4002兆3613億+5.35%
03/254,2684,2724,2084,267+0.47%797,6002兆3802億+6.44%
03/244,2654,2674,2114,247-0.54%909,2002兆3691億+6.18%
03/234,2004,2844,1854,270+2.94%1,137,0002兆3819億+7.02%
03/224,1884,2074,1354,148-0.43%1,693,9002兆3139億+4.27%
03/184,1744,1944,1054,166+0.99%1,852,5002兆3239億+4.81%
03/174,1084,1304,0674,125+2.51%1,446,9002兆3010億+3.88%
03/164,0304,0604,0234,024+1.28%925,7002兆2447億+1.33%
03/153,9353,9873,9203,973+1.27%662,7002兆2162億0%
03/143,9654,0233,9163,923-0.15%972,4002兆1883億-1.36%
03/113,9473,9663,9013,929-1.33%1,360,8002兆1917億-1.31%
03/103,8973,9973,8793,982+2.58%1,425,1002兆2213億-0.08%
03/093,8453,9093,8413,882+1.17%1,268,0002兆1655億-2.49%
03/083,8513,8873,8313,837-1.39%885,2002兆1404億-3.67%
03/073,9003,9083,8473,891-1.19%852,1002兆1705億-2.43%
03/043,9713,9823,9233,938-0.18%759,9002兆1967億-1.45%
03/033,9003,9573,8883,945+1.83%758,1002兆2006億-1.47%
03/023,8683,8913,8523,874-1.63%944,9002兆1610億-3.49%
03/014,0154,0293,9313,938-0.63%988,9002兆1967億-2.21%
02/283,9353,9873,9353,963+0.79%1,186,2002兆2107億-1.81%
02/253,9363,9493,8923,932+0.72%882,5002兆1934億-2.72%
02/243,9573,9613,8713,904-2.06%1,076,7002兆1777億-3.56%
02/224,0244,0243,9323,986-1.09%616,7002兆2235億-1.75%
02/214,0194,0433,9894,030-0.57%483,5002兆2480億-0.84%
02/183,9724,0573,9714,053+1.3%871,4002兆2609億-0.32%
02/174,0064,0303,9544,001-1.06%1,091,6002兆2319億-1.77%
02/164,0224,0574,0084,044+1.15%831,0002兆2558億-0.98%
02/153,9994,0323,9723,998+0.86%798,2002兆2302億-2.27%
02/143,9884,0443,9543,964-2.89%955,4002兆2112億-3.34%
02/1013:30 定款一部変更に関するお知らせ
02/1013:30 個別業績の前期実績との差異に関するお知らせ
02/1013:30 2021年12月期決算短信〔IFRS〕(連結)
02/104,0804,0994,0254,082+0.42%1,157,1002兆2770億-0.71%
02/094,1244,1244,0504,065-1.12%867,4002兆2676億-1.26%
02/084,1224,1394,0924,111+0.49%712,1002兆2932億-0.32%
02/074,0404,0994,0294,091+0.84%579,2002兆2821億-0.85%
02/044,0174,0634,0054,057+0.42%630,0002兆2631億-1.79%
02/033,9924,0403,9804,040+0.87%895,8002兆2536億-2.44%
02/023,9344,0313,9294,005+2.59%1,187,6002兆2341億-3.47%
02/013,9183,9593,8983,904-0.36%942,7002兆1777億-6.15%
01/313,9103,9413,8453,918-1.14%1,386,6002兆1855億-6.16%
01/284,0644,0803,9513,963-3.15%1,831,8002兆2107億-5.4%
01/2717:00 業績予想の修正に関するお知らせ
01/274,1664,1734,0544,092-1.02%667,3002兆2826億-2.59%
01/264,1834,1924,1244,134-1.64%883,8002兆3060億-1.69%
01/254,1804,2034,1384,203+0.05%790,9002兆3445億-0.12%
01/244,1534,2064,1454,201+1.16%779,0002兆3434億-0.24%
01/214,1234,1704,1014,153+0.56%569,7002兆3166億-1.38%
01/204,0874,1824,0874,130+1.35%761,5002兆3038億-1.92%
01/194,1094,1304,0574,075-1.36%856,7002兆2731億-3.21%
01/184,1644,1904,1264,131-0.41%549,9002兆3044億-1.9%
01/174,1194,1784,1134,148+1.52%668,8002兆3139億-1.5%
01/144,1314,1544,0764,086-3.27%1,368,1002兆2793億-2.99%
01/134,2414,2534,2024,224-1.12%898,1002兆3562億+0.21%
01/124,2504,2844,2314,272+0.87%1,115,3002兆3830億+1.52%
01/114,2844,3334,1954,235-0.31%1,283,2002兆3624億+0.83%
01/074,2374,2494,2104,248+0.85%1,002,4002兆3696億+1.34%
01/064,2604,2664,1924,212-0.64%791,8002兆3496億+0.67%
01/054,2114,2544,1974,239+0.4%750,1002兆3646億+1.39%
01/044,1844,2304,1714,222+1.27%887,1002兆3551億+1.17%
2021
12/304,1874,2154,1654,169-1.33%706,6002兆3256億+0.05%
12/294,2384,2514,2054,225-1.72%605,5002兆3568億+1.39%
12/284,2614,2994,2564,299+1.27%960,2002兆3981億+3.24%
12/274,2704,2724,2334,245-0.91%711,5002兆3680億+2.07%
12/244,3004,3004,2524,284+0.14%513,9002兆3897億+3.15%
12/234,2634,2784,2414,278+0.26%486,1002兆3864億+3.16%